248 related articles for article (PubMed ID: 35361502)
1. Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
Breakwell L; Marke D; Kaiser R; Tejada-Strop A; Pauly MD; Jabbi S; Yambasu S; Kabore HJ; Stewart B; Sesay T; Samba TT; Hayden T; Kamili S; Jambai A; Drobeniuc J; Singh T; Tohme RA; Wasley A
Vaccine; 2022 Apr; 40(19):2741-2748. PubMed ID: 35361502
[TBL] [Abstract][Full Text] [Related]
2. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
Woodring J; Pastore R; Brink A; Ishikawa N; Takashima Y; Tohme RA
MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(8):195-200. PubMed ID: 30817746
[TBL] [Abstract][Full Text] [Related]
3. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - World Health Organization African Region, 2016-2021.
Kabore HJ; Li X; Alleman MM; Manzengo CM; Mumba M; Biey J; Paluku G; Bwaka AM; Impouma B; Tohme RA
MMWR Morb Mortal Wkly Rep; 2023 Jul; 72(29):782-787. PubMed ID: 37471264
[TBL] [Abstract][Full Text] [Related]
4. Risk of early horizontal transmission of hepatitis B virus in children of uninfected mothers in sub-Saharan Africa: a systematic review and meta-analysis.
Ansari A; Vincent JP; Moorhouse L; Shimakawa Y; Nayagam S
Lancet Glob Health; 2023 May; 11(5):e715-e728. PubMed ID: 37061310
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
[TBL] [Abstract][Full Text] [Related]
6. Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021.
Khetsuriani N; Lesi O; Desai S; Armstrong PA; Tohme RA
MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(30):958-963. PubMed ID: 35900928
[TBL] [Abstract][Full Text] [Related]
7. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia.
E B; Ko K; Kim R; Nagashima S; Ouoba S; Hussain MRA; Sato T; Chuon C; Abe K; Sugiyama A; Takahashi K; Akita T; Tung R; Ork V; Hossain MS; Saphonn V; Tanaka J
BMC Infect Dis; 2023 Apr; 23(1):261. PubMed ID: 37101167
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018.
Minta AA; Silva MWT; Shrestha A; de Quiroz-Castro M; Tohme RA; Quimson ME; Jiz MA; Woodring J
Vaccine; 2021 Apr; 39(14):1982-1989. PubMed ID: 33712351
[TBL] [Abstract][Full Text] [Related]
9. Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.
Khetsuriani N; Tishkova F; Jabirov S; Wannemuehler K; Kamili S; Pirova Z; Mosina L; Gavrilin E; Ursu P; Drobeniuc J
Vaccine; 2015 Jul; 33(32):4019-24. PubMed ID: 26072015
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
Miao N; Zheng H; Sun X; Zhang G; Wang F
Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
[TBL] [Abstract][Full Text] [Related]
11. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
12. Progress Toward Hepatitis B Control - World Health Organization European Region, 2016-2019.
Khetsuriani N; Mosina L; Van Damme P; Mozalevskis A; Datta S; Tohme RA
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1029-1035. PubMed ID: 34324482
[TBL] [Abstract][Full Text] [Related]
13. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
Childs L; Roesel S; Tohme RA
Vaccine; 2018 Jan; 36(1):6-14. PubMed ID: 29174317
[TBL] [Abstract][Full Text] [Related]
14. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F
Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.
Mao B; Patel MK; Hennessey K; Duncan RJ; Wannemuehler K; Soeung SC
Vaccine; 2013 Sep; 31(40):4459-64. PubMed ID: 23684825
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
Breakwell L; Anga J; Cooley G; Ropiti L; Gwyn S; Wannemuehler K; Woodring J; Ogaoga D; Martin D; Patel M; Tohme RA
Vaccine; 2020 Jun; 38(30):4679-4686. PubMed ID: 32473876
[TBL] [Abstract][Full Text] [Related]
17. Maternal knowledge and infant uptake of valid hepatitis B vaccine birth dose at routine immunization clinics in Enugu State - Nigeria.
Okenwa UJ; Dairo MD; Bamgboye E; Ajumobi O
Vaccine; 2020 Mar; 38(12):2734-2740. PubMed ID: 32007294
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and associated knowledge of hepatitis B infection among healthcare workers in Freetown, Sierra Leone.
Qin YL; Li B; Zhou YS; Zhang X; Li L; Song B; Liu P; Yuan Y; Zhao ZP; Jiao J; Li J; Sun Y; Sevalie S; Kanu JE; Song YJ; Jiang JF; Sahr F; Jiang TJ;
BMC Infect Dis; 2018 Jul; 18(1):315. PubMed ID: 29986658
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
Gosset A; Diallo MY; Betsem E; Schaeffer L; Meda N; Vray M; Sombie R; Shimakawa Y; Boyer S
Vaccine; 2021 Jul; 39(33):4659-4670. PubMed ID: 34238606
[TBL] [Abstract][Full Text] [Related]
20. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
